The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Efficacy of switching from originator adalimumab to biosimilar adalimumab-AACF in patients with axial spondyloarthritis: a 12-month observational study”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2025 |
Lauren N. McGrath, David Moodie, Steven R. Feldman. Biologics and biosimilars in musculoskeletal diseases: addressing regulatory inconsistencies and clinical uncertainty, Exploration of Musculoskeletal Diseases. 2025; 3: 100798. https://doi.org/10.37349/emd.2025.100798 |
|
2 |
2026 |
Paulo Chicarone Pereira, Michel Alexandre Yazbek, Rafaela Bicalho Viana Macedo, Fabiana Miranda Moura, Antonio Luíz Boechat, Julio Cesar Bertacini de Moraes, Ricardo Machado Xavier, Hellen Mary da Silveira de Carvalho, Amanda de Miranda Marques, Francisco Airton Castro da Rocha, Fabiana Pompeo de Pina, Carla Gonçalves Schahin Saad, Claudia Diniz Lopes Marques, Karina Rossi Bonfiglioli, Ana Cristina de Medeiros Ribeiro, José Eduardo Martinez, Licia Maria Henrique da Mota, Marco Antonio Araújo da Rocha-Loures, Ivanio Alves Pereira, Claudia Goldenstein Schainberg, Alexandre Ibrahim Uehbe, Valderilio Feijó Azevedo. Position statement of the Biotechnology Committee of the Brazilian Society of Rheumatology on the interchangeability of originator and biosimilar biologics in immune-mediated rheumatic diseases, Advances in Rheumatology. 2026; https://doi.org/10.1186/s42358-026-00523-5 |